🚀 Acurx Pharmaceuticals is diving into the crypto world! The biopharma company plans to buy up to $1M in Bitcoin as a "treasury reserve asset." CEO David P. Luci sees Bitcoin as a strong store of value, especially with recent Bitcoin ETF approvals and institutional support.

📈 Following the announcement, Acurx shares jumped 6.6% in pre-market trading. What do you think about companies holding Bitcoin as a reserve asset? Share your thoughts in the comments!